<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35932023</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1755-8794</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC medical genomics</Title><ISOAbbreviation>BMC Med Genomics</ISOAbbreviation></Journal><ArticleTitle>Identification of TARDBP Gly298Ser as a founder mutation for amyotrophic lateral sclerosis in Southern China.</ArticleTitle><Pagination><StartPage>173</StartPage><MedlinePgn>173</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">173</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12920-022-01327-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by predominant impairment of upper and lower motor neurons. Over 50 TARDBP mutations have been reported in both familial (FALS) and sporadic ALS (SALS). Some mutations in TARDBP, e.g. A382T and G294V, have genetic founder effects in certain geographic regions. However, such prevalence and founder effect have not been reported in Chinese.</AbstractText><AbstractText Label="METHODS">Whole-exome sequencing (WES) was performed in 16 Chinese FALS patients, followed by Sanger sequencing for the TARDBP p.Gly298Ser mutation (G298S) in 798 SALS patients and 1,325 controls. Haplotype analysis using microsatellites flanking TARDBP was conducted in the G298S-carrying patients and noncarriers. The geographic distribution and phenotypic correlation of the TARDBP mutations reported worldwide were reviewed.</AbstractText><AbstractText Label="RESULTS">WES detected the TARDBP G298S mutation in 8 FALS patients, and Sanger sequencing found additional 8 SALS cases, but no controls, carrying this mutation. All the 16 cases came from Southern China, and 7 of these patients shared the 117-286-257-145-246-270 allele for the D1S2736-D1S1151-D1S2667-D1S489-D1S434-D1S2697 markers, which was not found in the 92 non-carrier patients (0/92) (p&#x2009;&lt;&#x2009;0.0001) and 65 age-matched and neurologically normal individuals (0/65) (p&#x2009;&lt;&#x2009;0.0001). The A382T and G298S mutations were prevalent in Europeans and Eastern Asians, respectively. Additionally, carriers for the M337V mutation are dominated by bulbar onset with a long survival, whereas those for G298S are dominated by limb onset with a short survival.</AbstractText><AbstractText Label="CONCLUSIONS">Some prevalent TARDBP mutations are distributed in a geographic pattern and related to clinical profiles. TARDBP G298S mutation is a founder mutation in the Southern Chinese ALS population.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Fanxi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No.45 Changchun Street, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Sen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xu-Ying</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No.45 Changchun Street, Beijing, 100053, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jianing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xiuli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Human Genome Center in Beijing, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Human Genome Center in Beijing, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhanjun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No.45 Changchun Street, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No.45 Changchun Street, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Junge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No.45 Changchun Street, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No.45 Changchun Street, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yanming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xusheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology of the First Medical Center, Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Xiaoli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China. yaoxiaol@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chaodong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, No.45 Changchun Street, Beijing, 100053, China. cdongwang01@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Genomics</MedlineTA><NlmUniqueID>101319628</NlmUniqueID><ISSNLinking>1755-8794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">Founder effect</Keyword><Keyword MajorTopicYN="N">G298S mutation</Keyword><Keyword MajorTopicYN="N">TARDBP</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>5</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35932023</ArticleId><ArticleId IdType="pmc">PMC9356425</ArticleId><ArticleId IdType="doi">10.1186/s12920-022-01327-4</ArticleId><ArticleId IdType="pii">10.1186/s12920-022-01327-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Shoai M, Fratta P, et al. Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36:1600.e5&#x2013;e8. doi: 10.1016/j.neurobiolaging.2014.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.12.017</ArticleId><ArticleId IdType="pubmed">25588603</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao B, Guo JF, Wang YQ, et al. C9orf72 mutation is rare in Alzheimer&#x2019;s disease, Parkinson's disease, and essential tremor in China. Front Cell Neurosci. 2013;7:164. doi: 10.3389/fncel.2013.00164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00164</ArticleId><ArticleId IdType="pmc">PMC3782144</ArticleId><ArticleId IdType="pubmed">24068985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EJ, Kwon JC, Park KH, et al. Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia. Neurobiol Aging. 2014;35:1213.e13&#x2013;e17. doi: 10.1016/j.neurobiolaging.2013.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.11.033</ArticleId><ArticleId IdType="pubmed">24387985</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Liu MS, Li XG, et al. Mutations in FUS are the most frequent genetic cause in juvenile sporadic ALS patients of Chinese origin. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:249&#x2013;252. doi: 10.3109/21678421.2016.1143012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143012</ArticleId><ArticleId IdType="pubmed">26972116</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Liu GL, et al. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Clin Genet. 2017;92:267&#x2013;273. doi: 10.1111/cge.13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.13015</ArticleId><ArticleId IdType="pubmed">28429524</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, Saxton AD, McMillan PJ, et al. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation. Acta Neuropathol. 2016;132:545&#x2013;561. doi: 10.1007/s00401-016-1600-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1600-y</ArticleId><ArticleId IdType="pmc">PMC5026939</ArticleId><ArticleId IdType="pubmed">27473149</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Zhang YJ, Baker M, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesiridis GS, Lee VM, Trojanowski JQ. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet. 2009;18:R156&#x2013;R162. doi: 10.1093/hmg/ddp303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp303</ArticleId><ArticleId IdType="pmc">PMC2758707</ArticleId><ArticleId IdType="pubmed">19808791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. 2011;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, et al. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Borghero G, Pugliatti M, et al. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol. 2011;68:594&#x2013;598. doi: 10.1001/archneurol.2010.352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.352</ArticleId><ArticleId IdType="pmc">PMC3513278</ArticleId><ArticleId IdType="pubmed">21220647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C, Giannini F, Intini E, et al. Genotype-phenotype correlation and evidence for a common ancestor in two Italian ALS patients with the D124G SOD1 mutation. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:611&#x2013;614. doi: 10.1080/21678421.2019.1621345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1621345</ArticleId><ArticleId IdType="pubmed">31170830</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistini S, Ricci C, Giannini F, et al. G41S SOD1 mutation: a common ancestor for six ALS Italian families with an aggressive phenotype. Amyotroph Lateral Scler. 2010;11:210&#x2013;215. doi: 10.3109/17482960902995592.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902995592</ArticleId><ArticleId IdType="pubmed">19488901</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M, Yang Y, Deng HX, et al. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology. 2009;72:1634&#x2013;1639. doi: 10.1212/01.wnl.0000343509.76828.2a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000343509.76828.2a</ArticleId><ArticleId IdType="pmc">PMC2683645</ArticleId><ArticleId IdType="pubmed">19176896</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma-Kozakiewicz M, Andersen PM, Elahi E, et al. Putative founder effect in the Polish, Iranian and United States populations for the L144S SOD1 mutation associated with slowly uniform phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:80&#x2013;85. doi: 10.1080/21678421.2020.1803359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1803359</ArticleId><ArticleId IdType="pubmed">32777948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, Al-Chalabi A, Zatz M. A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum Genet. 2005;118:499&#x2013;500. doi: 10.1007/s00439-005-0031-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-005-0031-y</ArticleId><ArticleId IdType="pubmed">16187141</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemann S, Joos H, Meyer T, et al. Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect. J Neurol Neurosurg Psychiatry. 2004;75:1186&#x2013;1188. doi: 10.1136/jnnp.2003.028324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.028324</ArticleId><ArticleId IdType="pmc">PMC1739190</ArticleId><ArticleId IdType="pubmed">15258228</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Newhouse S, Shatunov A, et al. The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet. 2013;21:102&#x2013;108. doi: 10.1038/ejhg.2012.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2012.98</ArticleId><ArticleId IdType="pmc">PMC3522204</ArticleId><ArticleId IdType="pubmed">22692064</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep. 2006;6:37&#x2013;46. doi: 10.1007/s11910-996-0008-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-996-0008-9</ArticleId><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging. 2014;35:2882.e7&#x2013;e12. doi: 10.1016/j.neurobiolaging.2014.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.012</ArticleId><ArticleId IdType="pmc">PMC4252367</ArticleId><ArticleId IdType="pubmed">25123918</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Wei Q, et al. Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis. Aging Dis. 2019;10:1199&#x2013;1206. doi: 10.14336/AD.2019.0215.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2019.0215</ArticleId><ArticleId IdType="pmc">PMC6844596</ArticleId><ArticleId IdType="pubmed">31788332</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Wu W, Xie Z, et al. Novel and recurrent mutations in a cohort of chinese patients with young-onset amyotrophic lateral sclerosis. Front Neurosci. 2019;13:1289. doi: 10.3389/fnins.2019.01289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01289</ArticleId><ArticleId IdType="pmc">PMC6908997</ArticleId><ArticleId IdType="pubmed">31866807</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XY, Cui Y, Jing D, et al. Novel PSEN1 and PSEN2 mutations identified in sporadic early-onset alzheimer disease and posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2021;35:208&#x2013;213. doi: 10.1097/WAD.0000000000000438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000438</ArticleId><ArticleId IdType="pmc">PMC8386585</ArticleId><ArticleId IdType="pubmed">33973882</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoni TB, Gonz&#xe1;lez-Salazar C, Rezende TJR, et al. A novel multisystem proteinopathy caused by a Missense ANXA11 variant. Ann Neurol. 2021;90:239&#x2013;252. doi: 10.1002/ana.26136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26136</ArticleId><ArticleId IdType="pubmed">34048612</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron DM, Fenton AR, Saez-Atienzar S, et al. ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function. Cell Rep. 2022;39:110598. doi: 10.1016/j.celrep.2022.110598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110598</ArticleId><ArticleId IdType="pmc">PMC9134378</ArticleId><ArticleId IdType="pubmed">35385738</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Chen SD, Feng SY, et al. Familial flail leg ALS caused by PFN1 mutation. J Neurol Neurosurg Psychiatry. 2020;91:223&#x2013;224. doi: 10.1136/jnnp-2019-321366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321366</ArticleId><ArticleId IdType="pubmed">31401564</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L, Picher-Martel V, Codron P, et al. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol Commun. 2019;7:103. doi: 10.1186/s40478-019-0758-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0758-7</ArticleId><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559&#x2013;575. doi: 10.1086/519795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/519795</ArticleId><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; S, Manolakos E, Orr&#xf9; N, et al. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;81:172&#x2013;178. doi: 10.1111/j.1399-0004.2011.01668.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2011.01668.x</ArticleId><ArticleId IdType="pubmed">21418058</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73:1162&#x2013;1169. doi: 10.1086/379378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/379378</ArticleId><ArticleId IdType="pmc">PMC1180495</ArticleId><ArticleId IdType="pubmed">14574645</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, van Es MA, Hennekam EA, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L, Pensato V, Croce R, et al. The first case of the TARDBP p.G294V mutation in a homozygous state: Is a single pathogenic allele sufficient to cause ALS? Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:273&#x2013;279. doi: 10.1080/21678421.2019.1704011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1704011</ArticleId><ArticleId IdType="pubmed">31852254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, Chen W, Huang P, et al. The distinct manifestation of young-onset amyotrophic lateral sclerosis in China. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:30&#x2013;37. doi: 10.1080/21678421.2020.1797091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1797091</ArticleId><ArticleId IdType="pubmed">32729724</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozaki I, Arai M, Takahashi K, et al. Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS. Intern Med. 2010;49:1209&#x2013;1212. doi: 10.2169/internalmedicine.49.3300.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.49.3300</ArticleId><ArticleId IdType="pubmed">20558945</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M, Born C, Rominger A, et al. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease. Neurobiol Aging. 2014;35:1212.e1&#x2013;e5. doi: 10.1016/j.neurobiolaging.2013.10.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.10.092</ArticleId><ArticleId IdType="pubmed">24300238</ArticleId></ArticleIdList></Reference><Reference><Citation>McGoldrick P, Joyce PI, Fisher EM, et al. Rodent models of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2013;1832:1421&#x2013;1436. doi: 10.1016/j.bbadis.2013.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.03.012</ArticleId><ArticleId IdType="pubmed">23524377</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu YF, Gendron TF, Zhang YJ, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Li X, Sun Y, et al. Genotype-phenotype correlations in a chinese population with familial amyotrophic lateral sclerosis. Neurol Res. 2022;44:206&#x2013;216. doi: 10.1080/01616412.2021.1968706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2021.1968706</ArticleId><ArticleId IdType="pubmed">34431456</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Chen X, Zhang S, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom Proteom Bioinform. 2021;S1672&#x2013;0229:00163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9039563</ArticleId><ArticleId IdType="pubmed">34400360</ArticleId></ArticleIdList></Reference><Reference><Citation>CNCB-NGDC Members and Partners: Xue Y, Bao Y, Zhang Z, et al. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res 2022,50: D27&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728233</ArticleId><ArticleId IdType="pubmed">34718731</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>